The goals of this project are to develop and validate a colorectal neoplasia risk prediction model among average-risk patients who underwent a baseline colonoscopy; estimate the risk of advanced neoplasia among patients with newly diagnosed Lynch Syndrome; and develop and validate a colorectal neoplasia risk prediction model among patients with newly diagnosed Lynch Syndrome.
COmprehensive risk Model for Predicting Advanced neoplasia on Surveillance Study (COMPASS)
Investigator: Lee, Jeffrey
Funder: Janssen Pharmaceuticals, Inc.
